What Are the Six Rs of Managing High-Risk Opioid Prescribing?
A structured framework for insurance professionals to address escalating opioid doses, safety concerns, and treatment modification.
Published: 4 April 2026
Introduction
When your claimant's opioid therapy shows signs of escalating risk or ineffectiveness, a systematic approach is essential. The Six Rs framework provides a structured method for intervening in high-risk opioid prescribing scenarios. This approach moves beyond simply approving or denying treatment to actively managing risk through progressive steps.
The Six Rs are: Recognise, Review, Reduce, Replace, Refer, and Reassess. Each step builds on the previous one, providing a logical progression from identifying a problem to implementing solutions. Understanding this framework helps you communicate more effectively with treating providers and demonstrates your claims management is based on evidence-based risk management principles.
The Six Rs Framework
1. Recognise: Identifying High-Risk Patterns
The first step is recognising that a prescribing pattern warrants closer management. High-risk scenarios include:
- Rapid dose escalation without corresponding pain or functional improvement
- Doses exceeding 90 mg morphine equivalent daily (MED) without specialist oversight
- Concurrent benzodiazepine or other sedating drug use
- Emergence of aberrant behaviour such as early refills, lost prescriptions, or multiple-prescriber visits detected via SafeScript
- Side effects worsening while doses escalate
- Long-term therapy (beyond 12 months) without documented ongoing clinical justification or functional improvement
- Patient showing signs of opioid-induced hyperalgesia or opioid tolerance with escalating pain despite higher doses
Your first responsibility is consistent surveillance. Are you systematically reviewing opioid claims against these risk indicators? If not, you're missing the opportunity to intervene early when changes are most likely to succeed.
2. Review: Comprehensive Assessment of Current Therapy
Once you recognise a high-risk pattern, the next step is a comprehensive review of whether current opioid therapy is meeting its goals. This review should address:
- Current vs. baseline: Compare current pain and function against baseline. If pain has not reduced by at least 30 percent and function has not improved proportionally, ask whether opioids are working.
- Dose justification: Why has the dose escalated? Is there documented clinical justification for each increase, or has the dose crept upward without clear rationale?
- Side effects: What side effects is the patient experiencing, and are they being actively managed? If sedation or cognitive effects are significant, opioid therapy may be impairing rather than helping function.
- Aberrant behaviour: Are there objective indicators of problematic medication use? SafeScript data, early refills, or urine drug screening results?
- Monitoring quality: Has monitoring actually occurred at the planned intervals, or has the patient been essentially unsupervised?
- Prescriber coordination: Are multiple providers involved in the patient's care? Is there evidence of communication between them?
This comprehensive review should be documented. Often, an independent medication review from a specialist pharmacist can provide objective assessment at this stage.
3. Reduce: Gradual Opioid Dose Reduction
If review identifies that opioid doses are higher than clinically justified or that side effects are outweighing benefits, dose reduction should be considered. This is where many claims managers struggle, but gradual dose reduction is evidence-based practice and should be supported.
Key principles for dose reduction:
- Gradual approach: Abrupt cessation of opioids can precipitate withdrawal symptoms. Reductions of 10-25 percent every 1-4 weeks are generally tolerable, though the rate should be individualised.
- Monitoring during reduction: The patient should be monitored closely for withdrawal symptoms, pain escalation, and mood changes during dose reduction.
- Concurrent strategies: As doses reduce, other pain management strategies should be intensified. This might include increased physical therapy, psychological support, or other medications.
- Clear communication: The patient should understand that dose reduction is occurring because the current dose is not meeting treatment goals, and alternative strategies are being implemented.
- Success criteria: What constitutes successful dose reduction? Often it's maintaining or improving pain and function at a lower dose, reducing side effects, and eliminating or reducing aberrant behaviour.
4. Replace: Substituting Alternative Pain Management Strategies
Reducing opioids without offering alternatives often fails. The fourth R addresses what will replace opioids in your pain management approach. Replacement strategies might include:
- Physical therapy and exercise: Structured physiotherapy programs are often more effective long-term than opioids for chronic pain and improve function.
- Psychological approaches: Cognitive behavioural therapy, mindfulness-based stress reduction, or acceptance and commitment therapy address pain-related distress and disability.
- Alternative medications: Anticonvulsants such as gabapentin or pregabalin, antidepressants such as duloxetine, topical analgesics, or NSAIDs may be more appropriate than opioids for certain pain conditions.
- Interventional procedures: For certain conditions, injections, nerve blocks, or spinal cord stimulation may be more effective than continued opioid escalation.
- Occupational therapy: Work re-training, ergonomics assessment, or functional restoration programs may address barriers to return to work.
The key is that replacement strategies are genuinely offered and supported, not just mentioned in passing. Does the claimant have a physiotherapy referral with clear goals? Has psychology been offered with an explanation of what it can achieve? Are alternative medications being trialled with clear monitoring?
5. Refer: Specialist Input for Complex Cases
When a case is complex, high-dose opioids are involved, or standard interventions are not working, specialist referral is appropriate. Specialists who may be involved include:
- Pain medicine specialists: For comprehensive pain management planning, particularly for high-dose therapy or when multiple opioids are being used concurrently.
- Addiction medicine specialists: When substance use concerns are present or when the prescribing pattern suggests medication misuse risk.
- Clinical pharmacists: For detailed medication review and assessment of drug interactions or medication-related problems.
- Psychologists or psychiatrists: When depression, anxiety, or post-traumatic stress disorder are complicating the clinical picture.
- Occupational health specialists: For workers compensation claims, to address return-to-work capacity and functional restoration.
Specialist referral should not be delayed when complexity warrants it. It's often more cost-effective to invest in specialist assessment early than to continue escalating interventions with a general practitioner.
6. Reassess: Regular Review Against Measurable Outcomes
The final R completes the cycle. After implementing Recognise, Review, Reduce, Replace, and Refer steps, you must reassess whether progress is being made. This reassessment should address:
- Is pain improving on new therapy regimen?
- Is function improving?
- Are side effects decreasing?
- Is the patient complying with new treatment plan?
- Has aberrant behaviour resolved?
- Is mental health stable?
If reassessment shows that interventions are working, you're on track. If reassessment shows no improvement, you may need to re-enter the cycle with new strategies or accept that opioids may need to be continued at current doses if all other approaches have failed.
The Six Rs in Practice: Claims Manager Implementation
| The "R" | What It Means | Claims Manager Action | Documentation to Request |
|---|---|---|---|
| Recognise | Identify high-risk prescribing patterns that warrant closer management | Systematically screen claims for high-risk indicators; flag claims for closer review | SafeScript reports; prescription records; dose history; baseline vs. current pain/function |
| Review | Conduct comprehensive assessment of whether current opioid therapy is meeting goals | Request independent medication review if internal assessment insufficient; compare outcomes against baseline | Medical records; monitoring documentation; outcome measurements; SafeScript reports; medication reconciliation |
| Reduce | Implement gradual opioid dose reduction if doses are unjustified or causing harm | Work with treating provider to establish dose reduction schedule; monitor during reduction phase | Dose reduction plan; monitoring records during reduction; patient tolerance to dose decrease; outcome measures |
| Replace | Implement alternative pain management strategies to address pain without escalating opioids | Ensure alternative strategies are genuinely offered and supported with resources or referrals | Referral documentation; physiotherapy program; psychology appointment confirmation; medication trial records; occupational therapy plan |
| Refer | Seek specialist input for complex cases or high-dose therapy | Facilitate specialist referral; ensure timely appointment and communication of findings back to treating provider | Specialist assessment reports; recommendations for treatment modification; documented discussion of recommendations with treating provider |
| Reassess | Evaluate whether Six Rs interventions are achieving intended outcomes | Schedule review at defined intervals; compare pre- and post-intervention outcomes; adjust strategy if needed | Updated pain and function scores; SafeScript reports; medication compliance records; specialist feedback; outcome measurements against established baseline |
Case Example: Applying the Six Rs
Scenario: Workers Compensation Claim with Escalating Opioid Doses
Recognise: You notice that over 18 months, your claimant's opioid dose has escalated from 20 mg to 110 mg MED daily. SafeScript shows recent visits to two different prescribers. Pain is documented as unchanged at baseline levels (8/10).
Review: You request medical records and SafeScript summary. Records show minimal monitoring, no documented baseline functional assessment, and no mention of non-opioid treatments trialled. Treating provider notes indicate patient "requests dose increases" without documented objective reason for escalation.
Reduce: You arrange independent medication review. The pharmacist recommends dose reduction, noting that current dose significantly exceeds PBS authority guidelines and pain benefit is not apparent. You work with the patient's general practitioner to establish a dose reduction schedule of 10-15% every 3 weeks, with close monitoring.
Replace: As doses reduce, you refer the patient to structured physiotherapy, psychology for pain-related cognitions, and request trial of gabapentin as adjunctive therapy. You fund these interventions as alternatives to opioid escalation.
Refer: Given the complexity, the high dose history, and multiple-prescriber involvement, you refer to a pain medicine specialist for comprehensive assessment and recommendations.
Reassess: At 12 weeks, you review outcomes. Pain is improved to 6/10, function is better, and the patient is managing the dose reduction better than expected. Side effects (sedation and constipation) have resolved. You continue the dose reduction trajectory and maintain monitoring.
Common Challenges and How to Address Them
Challenge: Treating Provider Resistance to Dose Reduction
If your treating provider resists dose reduction, ask them to complete the review step explicitly: "What evidence demonstrates that the current 110 mg MED is providing benefit? What pain and functional improvement is attributable to the opioid? At what dose did pain plateau?" Often, providers have not conducted this analysis explicitly.
Challenge: Patient Resistance to Dose Reduction
Patients may fear that dose reduction will worsen pain. Frame it as: "The current dose hasn't improved your pain as we'd hoped. Research shows that gradual dose reduction often improves overall wellbeing, reduces side effects, and reveals whether other treatments might be more effective." Include concurrent increase in other pain management strategies.
Challenge: Limited Non-Opioid Treatment Options Available
If your claimant is in a rural area with limited access to physiotherapy or psychology, consider telehealth options, exercise apps designed for pain management, or online cognitive behavioural therapy. Investment in these alternatives is often more cost-effective than continuing to escalate opioids.
Ready to implement the Six Rs framework in your claims management?
IMM provides comprehensive medication reviews and specialist consultation to support each step of the Six Rs process. From initial high-risk pattern recognition through reassessment of outcomes, our pharmacists work with you to implement systematic, evidence-based opioid management.
Explore IMM's High-Risk Opioid Management ServicesConclusion
The Six Rs framework transforms opioid management from reactive approval or denial into proactive, systematic risk management. By implementing Recognise, Review, Reduce, Replace, Refer, and Reassess in sequence, you're following evidence-based practices and demonstrating professional claims management. Whether your claimant ultimately continues opioids, reduces doses, or transitions to alternative management, this framework ensures the decision is based on measurable outcomes and systematic assessment rather than default patterns or cost considerations alone.
